Trials / Completed
CompletedNCT01170494
Effect of Vitamin D Oral Supplements on 25 OH Vitamin D Levels
Effect of Vitamin D Oral Supplements on 25 OH Vitamin D Levels: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 279 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Vitamin D deficiency is common world wide. 25 OH vitamin D level is the best indicator of vitamin D status. Vitamin D supplements are available as vitamin D2 or D3, in small daily or large weekly/monthly doses. Controversy continues on the relative potency of vitamin D2 compared to D3 and of daily compared to weekly or monthly doses, in increasing/maintaining total 25 OH vitamin D level. The investigators plan to conduct a controlled trial to compare the effect of various vitamin D supplements on 25 OH vitamin D levels in healthy adults with starting 25 OH vitamin D level between 20 to 50 nmol/L.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ergocalciferol 2000 IU orally, daily | ergocalciferol 2000 IU orally, daily |
| DRUG | ergocalciferol 25000 IU oraly every 2 weeks | ergocalciferol 25000 IU oraly every 2 weeks |
| DRUG | ergocalciferol 50000 IU orally every 4 weeks | ergocalciferol 50000 IU orally every 4 weeks |
| DRUG | ergocal1000 IU & cholecal 1000 IU orally daily | ergocalciferol 1000 IU and cholecalciferol 1000 IU orally every day |
| DRUG | cholecalciferol 2000 IU orally daily | cholecalciferol 2000 IU orally everyday |
| DRUG | Cholecalciferol 25000 IU orally every 2 weeks | Cholecalciferol 25000 IU orally every 2 weeks |
| DRUG | Cholecalciferol 50000 orally every 4 weeks | Cholecalciferol 50000 orally every 4 weeks |
| DRUG | placebo orally everyday | placebo orally everyday |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2010-07-27
- Last updated
- 2016-08-31
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT01170494. Inclusion in this directory is not an endorsement.